Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO730 | Escherichia coli | Species | Enterobacteriaceae | Bacteria |
PMID[21988831] |
|||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood | Geigy Scientific Tables, 8th Rev edition. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992. | ||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | saliva | DOI[10.1007/s11306-012-0464-y] | ||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | DOI[10.1038/nbt.2488] | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine |
PMID[24023812] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | cytoplasm |
PMID[15882454] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | cerebrospinal fluid |
PMID[15993662] |
||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[19425150] |
|||
NPO30171 | Lentinus edodes | Species | Lentinaceae | Eukaryota | TCM_Taiwan* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT4492 | Individual Protein | P2Y purinoceptor 1 | Meleagris gallopavo | EC50 | = | 8000 | nM | 12213051 |
NPT3826 | Individual Protein | Purinergic receptor P2Y2 | Homo sapiens | EC50 | > | 100000 | nM | 12213051 |
NPT4493 | Individual Protein | Purinergic receptor P2Y12 | Rattus norvegicus | EC50 | = | 69 | nM | 12213051 |
NPT2674 | Individual Protein | P2X purinoceptor 1 | Homo sapiens | EC50 | = | 10000 | nM | 12213051 |
NPT2670 | Individual Protein | P2X purinoceptor 2 | Homo sapiens | EC50 | > | 100000 | nM | 12213051 |
NPT2675 | Individual Protein | P2X purinoceptor 3 | Homo sapiens | EC50 | > | 100000 | nM | 12213051 |
NPT2671 | Individual Protein | P2X purinoceptor 4 | Rattus norvegicus | EC50 | = | 28000 | nM | 12213051 |
NPT4494 | Individual Protein | P2X purinoceptor 5 | Rattus norvegicus | EC50 | = | 18000 | nM | 12213051 |
NPT4495 | Individual Protein | P2X purinoceptor 6 | Rattus norvegicus | EC50 | = | 11000 | nM | 12213051 |
NPT3541 | Protein Family | Phosphatidylinositol 4-kinase, PI4K | Homo sapiens | IC50 | = | 145300 | nM | 2165159 |
NPT3541 | Protein Family | Phosphatidylinositol 4-kinase, PI4K | Homo sapiens | Ki | = | 100100 | nM | 2165159 |
NPT4497 | Individual Protein | HPr kinase | Bacillus subtilis (strain 168) | EC50 | = | 4300000 | nM | 15084125 |
NPT2 | Others | Unspecified | EC50 | = | 7400000 | nM | 15084125 | |
NPT2 | Others | Unspecified | Activity | = | 0.9 | 15084125 | ||
NPT2 | Others | Unspecified | Activity | = | 1.4 | 15084125 | ||
NPT2 | Others | Unspecified | Kd | = | 10000 | nM | 9089334 | |
NPT2 | Others | Unspecified | Activity | = | 34 | 15828813 | ||
NPT4500 | Individual Protein | Heat shock protein 90 beta | Canis lupus familiaris | EC50 | = | 21000 | nM | 16854066 |
NPT2264 | Protein Family | Heat shock protein HSP90 | Homo sapiens | EC50 | = | 87000 | nM | 16854066 |
NPT3582 | Individual Protein | Ketopantoate reductase | Escherichia coli K-12 | Kd | = | 360000 | nM | 16884311 |
NPT3582 | Individual Protein | Ketopantoate reductase | Escherichia coli K-12 | Ki | = | 1050000 | nM | 16884311 |
NPT1391 | Individual Protein | Pyrimidinergic receptor P2Y6 | Homo sapiens | Ratio EC50 | > | 7000 | 16942026 | |
NPT3826 | Individual Protein | Purinergic receptor P2Y2 | Homo sapiens | Ratio EC50 | = | 1.7 | 16942026 | |
NPT918 | Individual Protein | Heat shock protein HSP 90-alpha | Homo sapiens | EC50 | = | 120000 | nM | 16797988 |
NPT1391 | Individual Protein | Pyrimidinergic receptor P2Y6 | Homo sapiens | EC50 | = | 65000 | nM | 16942026 |
NPT2 | Others | Unspecified | Activity | = | 2500 | nmol/min/mg | 17353236 | |
NPT2 | Others | Unspecified | Activity | = | 2.5 | nmol | 17353236 | |
NPT2 | Others | Unspecified | Activity | = | 3.6 | nmol/min/mg | 17353236 | |
NPT2 | Others | Unspecified | Activity | = | 1060 | nmol/min/mg | 17353236 | |
NPT2 | Others | Unspecified | Activity | = | 0.3 | % | 17410128 | |
NPT4492 | Individual Protein | P2Y purinoceptor 1 | Meleagris gallopavo | EC50 | = | 100 | nM | 18760862 |
NPT2 | Others | Unspecified | IC50 | = | 500 | nM | 19256508 | |
NPT2 | Others | Unspecified | Kd | = | 500 | nM | 19256508 | |
NPT2 | Others | Unspecified | IC50 | > | 400000 | nM | 19256508 | |
NPT2 | Others | Unspecified | Kd | = | 4300 | nM | 19678707 | |
NPT2 | Others | Unspecified | Kd | = | 7300 | nM | 19678707 | |
NPT2 | Others | Unspecified | Kd | = | 20000 | nM | 19678707 | |
NPT2 | Others | Unspecified | Ratio | = | 5 | 19678707 | ||
NPT1601 | Individual Protein | 5'-nucleotidase | Rattus norvegicus | Ki | = | 0.91 | nM | 20146483 |
NPT3825 | Individual Protein | Purinergic receptor P2Y1 | Homo sapiens | EC50 | = | 14 | nM | 20175517 |
NPT832 | Individual Protein | Kinesin-like protein 1 | Homo sapiens | Activity | = | 4 | nanometer2/sec | 16892050 |
NPT832 | Individual Protein | Kinesin-like protein 1 | Homo sapiens | Activity | = | 771 | nanometer2/sec | 16892050 |
NPT4502 | Individual Protein | Heat shock cognate 71 kDa protein | Bos taurus | Kd | = | 110 | nM | 20608738 |
NPT2604 | Individual Protein | Heat shock cognate 71 kDa protein | Homo sapiens | Kd | = | 260 | nM | 20608738 |
NPT2628 | Individual Protein | Luciferase | Photuris pennsylvanica | Potency | = | 5011.9 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 50118.7 | nM | PubChem BioAssay data set |
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT1224 | Individual Protein | Glyceraldehyde-3-phosphate dehydrogenase liver | Homo sapiens | IC50 | > | 5000 | nM | PubChem BioAssay data set |
NPT2604 | Individual Protein | Heat shock cognate 71 kDa protein | Homo sapiens | IC50 | = | 280 | nM | PubChem BioAssay data set |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Kd | = | 2170 | nM | 21526763 |
NPT2 | Others | Unspecified | Kd | = | 500 | nM | 21526763 | |
NPT2 | Others | Unspecified | Ki | = | 110 | nM | 21526763 | |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Kd | = | 3830 | nM | 21526763 |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 1191.7 | nM | PubChem BioAssay data set | |
NPT681 | Cell Line | PC-12 | Rattus norvegicus | IC50 | = | 21000 | nM | 23751098 |
NPT2 | Others | Unspecified | IC50 | = | 30000 | nM | 23751098 | |
NPT2 | Others | Unspecified | IC50 | = | 170000 | nM | 23751098 | |
NPT3829 | Individual Protein | Purinergic receptor P2Y11 | Homo sapiens | EC50 | = | 1700 | nM | 23751098 |
NPT3825 | Individual Protein | Purinergic receptor P2Y1 | Homo sapiens | EC50 | = | 24 | nM | 23751098 |
NPT4504 | Individual Protein | Endoplasmin | Homo sapiens | Activity | = | 2.3 | nM | 23965125 |
NPT1429 | Individual Protein | Heat shock protein HSP 90-beta | Homo sapiens | Activity | = | 0.034 | nM | 23965125 |
NPT918 | Individual Protein | Heat shock protein HSP 90-alpha | Homo sapiens | Activity | = | 0.051 | nM | 23965125 |
NPT2264 | Protein Family | Heat shock protein HSP90 | Homo sapiens | Activity | = | 0.041 | nM | 23965125 |
NPT4505 | Individual Protein | Heat shock protein 75 kDa, mitochondrial | Homo sapiens | IC50 | = | 55594 | nM | 23965125 |
NPT4500 | Individual Protein | Heat shock protein 90 beta | Canis lupus familiaris | IC50 | = | 11447 | nM | 23965125 |
NPT1429 | Individual Protein | Heat shock protein HSP 90-beta | Homo sapiens | IC50 | = | 42159 | nM | 23965125 |
NPT918 | Individual Protein | Heat shock protein HSP 90-alpha | Homo sapiens | IC50 | = | 59308 | nM | 23965125 |
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.14 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.24 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.21 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.34 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.28 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 0.83 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.18 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 0.99 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.13 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 0.86 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.22 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 0.32 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.9 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.3 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.36 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.27 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.04 | 25611072 | |
NPT1434 | Individual Protein | Serine/threonine-protein kinase B-raf | Homo sapiens | Ratio | = | 1.42 | 25611072 | |
NPT2 | Others | Unspecified | IC50 | = | 170000 | nM | 26447940 | |
NPT3829 | Individual Protein | Purinergic receptor P2Y11 | Homo sapiens | EC50 | = | 1700 | nM | 26447940 |
NPT3825 | Individual Protein | Purinergic receptor P2Y1 | Homo sapiens | EC50 | = | 24 | nM | 26447940 |
NPT2 | Others | Unspecified | IC50 | = | 30000 | nM | 26447940 | |
NPT2 | Others | Unspecified | Inhibition | = | 40 | % | 26447940 | |
NPT2 | Others | Unspecified | IC50 | = | 250000 | nM | 26447940 | |
NPT681 | Cell Line | PC-12 | Rattus norvegicus | IC50 | = | 21000 | nM | 26447940 |
NPT2 | Others | Unspecified | EC50 | = | 19000 | nM | 26447940 | |
NPT2604 | Individual Protein | Heat shock cognate 71 kDa protein | Homo sapiens | Kd | = | 323.59 | nM | 27119979 |
NPT2604 | Individual Protein | Heat shock cognate 71 kDa protein | Homo sapiens | Kd | = | 320 | nM | 27119979 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC130586 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC164952 |
0.9929 | High Similarity | NPC174802 |
0.9857 | High Similarity | NPC85689 |
0.9857 | High Similarity | NPC185991 |
0.9857 | High Similarity | NPC211025 |
0.979 | High Similarity | NPC226245 |
0.9787 | High Similarity | NPC321814 |
0.9718 | High Similarity | NPC302778 |
0.9718 | High Similarity | NPC212551 |
0.9716 | High Similarity | NPC161224 |
0.9653 | High Similarity | NPC316618 |
0.9643 | High Similarity | NPC121222 |
0.9583 | High Similarity | NPC224076 |
0.9459 | High Similarity | NPC323091 |
0.9429 | High Similarity | NPC107374 |
0.9429 | High Similarity | NPC21448 |
0.9429 | High Similarity | NPC156461 |
0.9362 | High Similarity | NPC189068 |
0.9362 | High Similarity | NPC164665 |
0.9296 | High Similarity | NPC269827 |
0.9296 | High Similarity | NPC219313 |
0.9296 | High Similarity | NPC309832 |
0.9286 | High Similarity | NPC229974 |
0.9143 | High Similarity | NPC161659 |
0.9143 | High Similarity | NPC209525 |
0.902 | High Similarity | NPC324033 |
0.902 | High Similarity | NPC321458 |
0.9014 | High Similarity | NPC314152 |
0.9007 | High Similarity | NPC317821 |
0.898 | High Similarity | NPC472816 |
0.8974 | High Similarity | NPC326529 |
0.8954 | High Similarity | NPC261595 |
0.8917 | High Similarity | NPC324198 |
0.8917 | High Similarity | NPC319100 |
0.8917 | High Similarity | NPC189261 |
0.8839 | High Similarity | NPC326082 |
0.8742 | High Similarity | NPC239737 |
0.8725 | High Similarity | NPC207633 |
0.8671 | High Similarity | NPC129756 |
0.8591 | High Similarity | NPC150853 |
0.8523 | High Similarity | NPC136349 |
0.8497 | Intermediate Similarity | NPC313754 |
0.8497 | Intermediate Similarity | NPC311197 |
0.8497 | Intermediate Similarity | NPC54320 |
0.8472 | Intermediate Similarity | NPC30326 |
0.8431 | Intermediate Similarity | NPC52238 |
0.8378 | Intermediate Similarity | NPC177169 |
0.8355 | Intermediate Similarity | NPC328479 |
0.8345 | Intermediate Similarity | NPC33996 |
0.8333 | Intermediate Similarity | NPC320818 |
0.8322 | Intermediate Similarity | NPC232408 |
0.8322 | Intermediate Similarity | NPC64705 |
0.8311 | Intermediate Similarity | NPC211820 |
0.8311 | Intermediate Similarity | NPC251233 |
0.8311 | Intermediate Similarity | NPC318590 |
0.8255 | Intermediate Similarity | NPC317746 |
0.8255 | Intermediate Similarity | NPC89147 |
0.8255 | Intermediate Similarity | NPC274384 |
0.8176 | Intermediate Similarity | NPC186619 |
0.8105 | Intermediate Similarity | NPC326694 |
0.8089 | Intermediate Similarity | NPC195140 |
0.8025 | Intermediate Similarity | NPC93365 |
0.795 | Intermediate Similarity | NPC324484 |
0.7914 | Intermediate Similarity | NPC290959 |
0.7901 | Intermediate Similarity | NPC325906 |
0.7838 | Intermediate Similarity | NPC61198 |
0.7826 | Intermediate Similarity | NPC14590 |
0.777 | Intermediate Similarity | NPC262926 |
0.7658 | Intermediate Similarity | NPC321052 |
0.7619 | Intermediate Similarity | NPC313897 |
0.7584 | Intermediate Similarity | NPC319221 |
0.7517 | Intermediate Similarity | NPC324009 |
0.7514 | Intermediate Similarity | NPC24589 |
0.7486 | Intermediate Similarity | NPC282458 |
0.7486 | Intermediate Similarity | NPC78941 |
0.7308 | Intermediate Similarity | NPC74306 |
0.7308 | Intermediate Similarity | NPC315642 |
0.7191 | Intermediate Similarity | NPC313514 |
0.716 | Intermediate Similarity | NPC33382 |
0.7118 | Intermediate Similarity | NPC168702 |
0.7118 | Intermediate Similarity | NPC125659 |
0.7035 | Intermediate Similarity | NPC222174 |
0.7005 | Intermediate Similarity | NPC276373 |
0.6968 | Remote Similarity | NPC5802 |
0.6965 | Remote Similarity | NPC107160 |
0.6931 | Remote Similarity | NPC157821 |
0.6923 | Remote Similarity | NPC321393 |
0.6863 | Remote Similarity | NPC21461 |
0.6824 | Remote Similarity | NPC327579 |
0.6763 | Remote Similarity | NPC158055 |
0.6624 | Remote Similarity | NPC57279 |
0.662 | Remote Similarity | NPC476564 |
0.6603 | Remote Similarity | NPC246193 |
0.6603 | Remote Similarity | NPC104011 |
0.6535 | Remote Similarity | NPC250178 |
0.6525 | Remote Similarity | NPC174114 |
0.6525 | Remote Similarity | NPC87981 |
0.6494 | Remote Similarity | NPC248007 |
0.6395 | Remote Similarity | NPC4837 |
0.6395 | Remote Similarity | NPC312187 |
0.6327 | Remote Similarity | NPC103388 |
0.6299 | Remote Similarity | NPC139776 |
0.6289 | Remote Similarity | NPC287876 |
0.6226 | Remote Similarity | NPC160666 |
0.6226 | Remote Similarity | NPC14330 |
0.6164 | Remote Similarity | NPC18335 |
0.6149 | Remote Similarity | NPC472834 |
0.6013 | Remote Similarity | NPC109322 |
0.5935 | Remote Similarity | NPC68938 |
0.5882 | Remote Similarity | NPC164845 |
0.5849 | Remote Similarity | NPC5707 |
0.5848 | Remote Similarity | NPC217656 |
0.5844 | Remote Similarity | NPC313547 |
0.5814 | Remote Similarity | NPC89139 |
0.5799 | Remote Similarity | NPC296437 |
0.5776 | Remote Similarity | NPC180493 |
0.5765 | Remote Similarity | NPC470266 |
0.5732 | Remote Similarity | NPC189314 |
0.5714 | Remote Similarity | NPC244700 |
0.5705 | Remote Similarity | NPC476561 |
0.5698 | Remote Similarity | NPC476433 |
0.5698 | Remote Similarity | NPC476528 |
0.567 | Remote Similarity | NPC265111 |
0.5667 | Remote Similarity | NPC472833 |
0.5665 | Remote Similarity | NPC476522 |
0.5665 | Remote Similarity | NPC476520 |
0.5665 | Remote Similarity | NPC474986 |
0.5665 | Remote Similarity | NPC476013 |
0.5657 | Remote Similarity | NPC476408 |
0.5632 | Remote Similarity | NPC476521 |
0.5625 | Remote Similarity | NPC473585 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC130586 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD338 | Approved |
0.9929 | High Similarity | NPD339 | Approved |
0.9857 | High Similarity | NPD283 | Approved |
0.9718 | High Similarity | NPD242 | Approved |
0.9583 | High Similarity | NPD169 | Phase 2 |
0.9429 | High Similarity | NPD249 | Approved |
0.9429 | High Similarity | NPD250 | Approved |
0.9296 | High Similarity | NPD195 | Approved |
0.9296 | High Similarity | NPD186 | Discovery |
0.9014 | High Similarity | NPD185 | Approved |
0.8954 | High Similarity | NPD247 | Clinical (unspecified phase) |
0.8919 | High Similarity | NPD1750 | Clinical (unspecified phase) |
0.8919 | High Similarity | NPD3107 | Discontinued |
0.8919 | High Similarity | NPD1369 | Phase 2 |
0.8917 | High Similarity | NPD4171 | Clinical (unspecified phase) |
0.8889 | High Similarity | NPD166 | Approved |
0.8873 | High Similarity | NPD193 | Suspended |
0.8861 | High Similarity | NPD1412 | Clinical (unspecified phase) |
0.8831 | High Similarity | NPD7988 | Suspended |
0.875 | High Similarity | NPD4716 | Approved |
0.8742 | High Similarity | NPD2624 | Phase 2 |
0.8742 | High Similarity | NPD1732 | Phase 3 |
0.8742 | High Similarity | NPD2646 | Discontinued |
0.8696 | High Similarity | NPD4744 | Clinical (unspecified phase) |
0.8636 | High Similarity | NPD3083 | Approved |
0.8523 | High Similarity | NPD548 | Clinical (unspecified phase) |
0.8497 | Intermediate Similarity | NPD217 | Approved |
0.8497 | Intermediate Similarity | NPD219 | Phase 3 |
0.8497 | Intermediate Similarity | NPD218 | Approved |
0.8497 | Intermediate Similarity | NPD216 | Approved |
0.8497 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.8485 | Intermediate Similarity | NPD6417 | Clinical (unspecified phase) |
0.8383 | Intermediate Similarity | NPD2632 | Approved |
0.8383 | Intermediate Similarity | NPD2630 | Approved |
0.8383 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.8302 | Intermediate Similarity | NPD2647 | Phase 3 |
0.8301 | Intermediate Similarity | NPD214 | Approved |
0.8301 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.8112 | Intermediate Similarity | NPD248 | Discontinued |
0.8049 | Intermediate Similarity | NPD5666 | Phase 2 |
0.8042 | Intermediate Similarity | NPD9633 | Phase 3 |
0.8025 | Intermediate Similarity | NPD546 | Clinical (unspecified phase) |
0.8013 | Intermediate Similarity | NPD7158 | Phase 1 |
0.7986 | Intermediate Similarity | NPD9632 | Phase 3 |
0.7958 | Intermediate Similarity | NPD9408 | Phase 3 |
0.7901 | Intermediate Similarity | NPD1776 | Approved |
0.7901 | Intermediate Similarity | NPD1777 | Approved |
0.7871 | Intermediate Similarity | NPD3085 | Phase 1 |
0.7862 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.7847 | Intermediate Similarity | NPD870 | Clinical (unspecified phase) |
0.7838 | Intermediate Similarity | NPD252 | Clinical (unspecified phase) |
0.7821 | Intermediate Similarity | NPD3086 | Phase 3 |
0.7719 | Intermediate Similarity | NPD1692 | Approved |
0.7654 | Intermediate Similarity | NPD516 | Clinical (unspecified phase) |
0.7632 | Intermediate Similarity | NPD3695 | Approved |
0.7632 | Intermediate Similarity | NPD3696 | Approved |
0.7632 | Intermediate Similarity | NPD549 | Approved |
0.763 | Intermediate Similarity | NPD5682 | Phase 3 |
0.763 | Intermediate Similarity | NPD5683 | Clinical (unspecified phase) |
0.763 | Intermediate Similarity | NPD5684 | Clinical (unspecified phase) |
0.76 | Intermediate Similarity | NPD4054 | Clinical (unspecified phase) |
0.7533 | Intermediate Similarity | NPD194 | Clinical (unspecified phase) |
0.7438 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD582 | Approved |
0.7261 | Intermediate Similarity | NPD4240 | Approved |
0.7215 | Intermediate Similarity | NPD171 | Discontinued |
0.7205 | Intermediate Similarity | NPD3708 | Phase 2 |
0.7191 | Intermediate Similarity | NPD7138 | Phase 2 |
0.716 | Intermediate Similarity | NPD353 | Discontinued |
0.7135 | Intermediate Similarity | NPD1063 | Phase 2 |
0.7012 | Intermediate Similarity | NPD231 | Clinical (unspecified phase) |
0.6984 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.6947 | Remote Similarity | NPD2876 | Phase 3 |
0.6947 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6939 | Remote Similarity | NPD5080 | Phase 2 |
0.6909 | Remote Similarity | NPD9605 | Phase 3 |
0.6888 | Remote Similarity | NPD5079 | Phase 2 |
0.6875 | Remote Similarity | NPD2824 | Phase 2 |
0.6871 | Remote Similarity | NPD9606 | Approved |
0.6824 | Remote Similarity | NPD9607 | Approved |
0.6798 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6763 | Remote Similarity | NPD6840 | Approved |
0.6735 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.6735 | Remote Similarity | NPD2902 | Phase 2 |
0.6688 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD9409 | Discontinued |
0.6633 | Remote Similarity | NPD4495 | Phase 1 |
0.6624 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.6554 | Remote Similarity | NPD9374 | Approved |
0.6552 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6545 | Remote Similarity | NPD1730 | Discontinued |
0.6531 | Remote Similarity | NPD9373 | Approved |
0.6519 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.6494 | Remote Similarity | NPD9084 | Phase 2 |
0.649 | Remote Similarity | NPD307 | Approved |
0.6456 | Remote Similarity | NPD282 | Approved |
0.6438 | Remote Similarity | NPD1119 | Phase 2 |
0.6369 | Remote Similarity | NPD775 | Approved |
0.633 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.6303 | Remote Similarity | NPD1431 | Approved |
0.6303 | Remote Similarity | NPD2253 | Discontinued |
0.6303 | Remote Similarity | NPD1430 | Approved |
0.6289 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.6273 | Remote Similarity | NPD1058 | Discontinued |
0.6273 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.6243 | Remote Similarity | NPD207 | Discontinued |
0.6225 | Remote Similarity | NPD9584 | Phase 2 |
0.6224 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.6224 | Remote Similarity | NPD4458 | Phase 2 |
0.6213 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.6164 | Remote Similarity | NPD1127 | Approved |
0.6164 | Remote Similarity | NPD8836 | Approved |
0.6164 | Remote Similarity | NPD1128 | Approved |
0.6139 | Remote Similarity | NPD281 | Approved |
0.6121 | Remote Similarity | NPD799 | Phase 1 |
0.6121 | Remote Similarity | NPD1808 | Phase 1 |
0.6077 | Remote Similarity | NPD6381 | Phase 2 |
0.6061 | Remote Similarity | NPD6112 | Approved |
0.6048 | Remote Similarity | NPD1118 | Discontinued |
0.604 | Remote Similarity | NPD9417 | Phase 3 |
0.604 | Remote Similarity | NPD9416 | Phase 3 |
0.6026 | Remote Similarity | NPD9375 | Discontinued |
0.6013 | Remote Similarity | NPD798 | Discontinued |
0.6 | Remote Similarity | NPD1120 | Approved |
0.6 | Remote Similarity | NPD1121 | Approved |
0.6 | Remote Similarity | NPD535 | Approved |
0.5956 | Remote Similarity | NPD9582 | Phase 3 |
0.595 | Remote Similarity | NPD5486 | Discontinued |
0.5946 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.5944 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.5939 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.592 | Remote Similarity | NPD4713 | Clinical (unspecified phase) |
0.592 | Remote Similarity | NPD34 | Approved |
0.592 | Remote Similarity | NPD4714 | Approved |
0.592 | Remote Similarity | NPD4715 | Clinical (unspecified phase) |
0.5917 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.5901 | Remote Similarity | NPD515 | Phase 1 |
0.5882 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5867 | Remote Similarity | NPD8250 | Phase 2 |
0.5867 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.5862 | Remote Similarity | NPD5458 | Discontinued |
0.5859 | Remote Similarity | NPD691 | Discontinued |
0.5849 | Remote Similarity | NPD8830 | Phase 3 |
0.5833 | Remote Similarity | NPD2450 | Phase 2 |
0.5833 | Remote Similarity | NPD2451 | Phase 2 |
0.5833 | Remote Similarity | NPD2452 | Phase 2 |
0.5833 | Remote Similarity | NPD2453 | Phase 2 |
0.5822 | Remote Similarity | NPD6036 | Suspended |
0.5806 | Remote Similarity | NPD9406 | Approved |
0.5795 | Remote Similarity | NPD7842 | Phase 2 |
0.5776 | Remote Similarity | NPD78 | Approved |
0.5776 | Remote Similarity | NPD9544 | Approved |
0.5756 | Remote Similarity | NPD796 | Phase 2 |
0.5732 | Remote Similarity | NPD8831 | Approved |
0.5732 | Remote Similarity | NPD8833 | Approved |
0.5705 | Remote Similarity | NPD757 | Phase 3 |
0.5696 | Remote Similarity | NPD9360 | Approved |
0.5683 | Remote Similarity | NPD5768 | Phase 2 |
0.5682 | Remote Similarity | NPD5627 | Approved |
0.5681 | Remote Similarity | NPD537 | Phase 2 |
0.5681 | Remote Similarity | NPD534 | Phase 2 |
0.5644 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.5633 | Remote Similarity | NPD6351 | Discovery |
0.5633 | Remote Similarity | NPD1368 | Approved |
0.5625 | Remote Similarity | NPD3849 | Clinical (unspecified phase) |
0.561 | Remote Similarity | NPD1775 | Approved |
0.561 | Remote Similarity | NPD1085 | Approved |
0.5607 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
PubChem CID   | 6022 |
ChEMBL   | CHEMBL14830 |
ZINC   |
Molecular Weight:   | 427.03 |
ALogP:   | -2.4947 |
MLogP:   | 0.69 |
XLogP:   | -4.696 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 252.22 |
# H-Bond Aceptor:   | 15 |
# H-Bond Donor:   | 6 |
# Rings:   | 3 |
# Heavy Atoms:   | 27 |